Get Fit Bharat

Tag: HIIT

HomeHIIT

Safex Chemicals Group, a leader in the chemical industry, marks its 34th Foundation Day with the launch of an inspiring employee engagement campaign that bridges its storied past with its ambitious future. The idea of Safex was conceived by Late Mr. S.K. Jindal and Mr. S.K. Chaudhary at a time when the Indian agrochemical …

The Board of Directors of Arjo and Joacim Lindoff have come to an agreement which implicates Joacim leaving his position as President & CEO of Arjo, a role he has held since 2017. Niclas Sjöswärd, currently CFO of Arjo, has been appointed interim President & CEO. The process of recruiting …

New York, United States:  Starr announced that Peter Hirs has been named the company’s chief financial officer, effective January 13, succeeding Howard I. Smith, who is retiring after more than 40 years at Starr and related entities.   This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250113071409/en/   …

PopVax, an Indian full-stack biotechnology company developing broadly-protective mRNA vaccines using machine learning-enabled computational protein design, is delighted to announce that it has been awarded $2 million by the United States Biomedical Advanced Research and Development Authority (BARDA) as one of the winners of the Concept Stage of BARDA’s Patch Forward Prize for its seasonal …

Information about various derivatives that will be listed at NGM. For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, …

Stock Exchange Release 13.01.2025 at 18:30 EET/EEST   FISKARS CORPORATION: ACQUISITION OF OWN SHARES 13.01.2025   Date 13.01.2025   Exchange transaction Buy   Share class FSKRS   Amount  2000   Average price/share 14.5861 EUR Highest price/share 14.6200 EUR Lowest price/share 14.5000 EUR Total price 29,172.20 EUR       The …

Stockholm, January 14, 2025 – BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) today announced that the U.S. Food and Drug Administration (FDA) has accepted BioArctic’s partner Eisai’s Biologics License Application (BLA) for Leqembi subcutaneous autoinjector (SC-AI) for weekly maintenance dosingLeqembi is indicated for the treatment of Alzheimer’s disease (AD) in patients …

STOCKHOLM, SWEDEN – January 13, 2025 – OncoZenge AB (publ) (“OncoZenge” or the “Company”), announces that the Company has entered into a non-binding agreement with the intention to partner with pharmaceutical leader Molteni Farmaceutici (“Molteni”) regarding exclusive rights to commercialization of BupiZenge™ in Europe. The Company has signed a non-binding …